PNC Financial Services Group’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
ACM
HWAM
TE
AA
LCM
PNC Financial Services Group's NUVB Position: Q2 2026 in Review
PNC Financial Services Group increased its Nuvation Bio (NUVB) stake by 5.5% in Q2 2026, buying an estimated $2.36K and bringing the position to 9,307 shares worth $52.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3314.
PNC Financial Services Group first reported a position in NUVB in Q1 2021 and has held it in 22 quarters since. The position peaked at $83.7K in Q4 2025. 91 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.
- PNC Financial Services Group held 9,307 shares of Nuvation Bio worth $52.9K as of Q2 2026.
- PNC Financial Services Group bought 483 Nuvation Bio shares in Q2 2026, an estimated $2.36K.
- Nuvation Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3314 holding.
- PNC Financial Services Group first reported a position in Nuvation Bio in Q1 2021 and has held it in 22 quarters since.
- PNC Financial Services Group's Nuvation Bio position peaked at $83.7K in Q4 2025.
- 91 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.